High-sensitivity C-reactive protein measures low-grade systemic inflammation. The liver produces CRP in response to inflammatory signaling throughout the body, and the high-sensitivity assay detects levels far below what standard CRP testing can.
Chronic low-grade inflammation silently accelerates cardiovascular disease, insulin resistance, and cognitive decline, and hs-CRP is the most accessible marker of that process. The longevity consensus targets hs-CRP under 1.0 mg/L, meaningfully tighter than typical clinical "normal" ranges. Acute infections or recent injuries will transiently elevate the marker, so results shortly after illness shouldn't drive long-term decisions.
Optimal C-Reactive Protein: 0-1 mg/L.
Typically re-tested every 8 weeks.
Many labs report 0 to 3 mg/L as a typical reference range for adults, and the result is most informative when it is tracked over time rather than read once.
C-reactive protein is an acute-phase protein made by liver cells and released into the bloodstream when the immune system responds to infection, tissue injury or chronic irritation.
The mechanism is fairly direct. When immune cells encounter damage or a pathogen, they release signalling molecules, and interleukin-6 is the main one that instructs the liver to ramp up CRP production[1]. That cytokine-to-liver pathway is why drugs that block interleukin signalling lower circulating CRP, a relationship studied in cardiovascular medicine[2]. Once in circulation, CRP binds to phosphocholine exposed on damaged cell membranes and on the surface of some bacteria, helping flag them for clearance by complement proteins and immune cells.
Two practical points follow. First, CRP responds quickly, rising within hours of a stimulus and falling again once the stimulus resolves, which makes it a real-time signal rather than a long-term average. Second, it is non-specific. A sprained ankle, a chest infection, gum disease and smouldering metabolic inflammation can all push the same number up, so the value is a prompt for context, never an answer on its own.
Standard CRP and high-sensitivity CRP measure the same molecule. The high-sensitivity assay simply resolves the low end of the range accurately, which is what matters when the question is long-term cardiovascular and metabolic risk rather than acute illness.
It matters because it tracks a process that drives chronic disease, not just one that accompanies it.
Atherosclerosis is now understood as an inflammatory process as much as a lipid one, with innate immune pathways such as the NLRP3 inflammasome implicated in plaque development and thrombosis[3]. High-sensitivity CRP has been studied extensively as a way to refine cardiovascular risk estimates beyond cholesterol alone[4], and cardiology reviews describe it as one of the better-characterised inflammatory markers available in routine practice[5].
The comparative data are striking. In a collaborative analysis of three randomised trials of patients already receiving statin therapy, hs-CRP was a stronger predictor of future cardiovascular events and mortality than LDL cholesterol[6]. A 30-year follow-up study in women reported that hs-CRP, LDL cholesterol and lipoprotein(a) each contributed independently to long-term cardiovascular outcomes, so inflammation added information that cholesterol alone did not capture[7].
The relevance is not limited to arteries. Inflammatory skin disease sits alongside accelerated atherosclerosis, and psoriasis has been studied as a model of how systemic inflammation connects skin and vessels[8]. Research also suggests inflammatory signalling may be relevant in psychiatry, with hs-CRP examined as an early transdiagnostic marker in mood disorders[9]. None of this makes CRP a diagnostic test. It makes it a cheap, repeatable read on a process worth knowing about years before symptoms appear.
Most adult results fall under 3 mg/L on a standard reference range, while optimization targets sit lower.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| C-reactive protein (CRP, hs-CRP) | 0 to 3 mg/L | 0 to 1 mg/L |
CRP has no single agreed range by sex and age. In 4,058 adults the upper end ran higher in men than in women, and it was a little higher from age 55, though that age difference was not statistically significant. US national data suggest adjusting the upper limit for age and sex.[13][14]
| Sex | Age | Upper limit, 95th percentile (mg/L) |
|---|---|---|
| Men | 30 to 64 | Up to 6.28 |
| Women | 30 to 64 | Up to 4.01 |
| Men and women | Under 55 | Up to 4.68 |
| Men and women | 55 and over | Up to 5.35 |
These are upper limits from a community study that included people with metabolic conditions, so they are wider than the targets often used for heart risk.[13] Your own lab's printed range is the one to read your result against.
Reference ranges vary by lab, assay, age and sex, so always read your result against the range printed on your own report. The optimal range shown is FitScript's optimization target, not a diagnostic cut-off, and it is not used to rule a condition in or out.
Cardiology literature has long grouped hs-CRP results into broad tiers for risk discussion, summarised below for orientation only[4],[5].
| hs-CRP result | How it is commonly described |
|---|---|
| Under 1 mg/L | Lower relative cardiovascular risk |
| 1 to 3 mg/L | Average relative risk |
| Above 3 mg/L | Higher relative risk, worth repeating when well |
| Above 10 mg/L | Usually reflects acute inflammation; generally rechecked rather than read as baseline risk |
One unit note. CRP is usually reported in mg/L, but some labs report mg/dL, where 1 mg/dL equals 10 mg/L. Check the unit before comparing two reports.
A high result means measurable inflammation is active somewhere in the body, and the number alone says nothing about where it is or why.
Symptoms people report with a raised reading include fatigue, sluggish training recovery, morning joint stiffness, low mood and a general run-down feeling. Plenty of people with an elevated hs-CRP feel entirely well, which is precisely why it is measured rather than guessed at.
Common causes are wide-ranging. Acute infection, dental infection, recent surgery or injury, autoimmune and inflammatory conditions, excess body fat (particularly visceral fat), smoking, disrupted sleep, pregnancy, oral oestrogen-containing medication and an unusually hard training session in the days before the draw can all raise the value. A result above roughly 10 mg/L usually reflects an acute process, and because an acute spike tells you little about baseline risk, it is typically rechecked once the person has recovered[4].
The long-term angle is about persistence, not peaks. Inflammation that stays elevated despite good cholesterol control has been described as residual inflammatory risk, and it predicted events in statin-treated trial populations[6] and across decades of follow-up in women[7]. Residual inflammation can persist even when the underlying condition looks controlled, as observed in prospective cohorts of people with psoriasis receiving biologic therapy[10].
So the sequence is observation, then meaning, then next step. The observation is a number above the typical range. The meaning may be transient and trivial, or it may reflect an ongoing process worth understanding. The next step is to repeat the test when you are free of acute illness and review the trend with a clinician alongside your lipids, metabolic markers and history. A markedly high reading accompanied by fever, severe pain, new swelling or unexplained weight loss is worth discussing with a clinician promptly.
A low result usually means there was little measurable systemic inflammation at the moment of the blood draw, which in most contexts is a favourable finding.
There are no symptoms of a low CRP. People in this range often describe steady energy and good recovery, but that is a correlation with general health rather than something the protein itself produces.
Common causes are unremarkable in the best way, a lean body composition, regular aerobic activity, no smoking, adequate sleep and no current infection. Some medical treatments also lower it. Statin therapy reduced inflammatory markers alongside cholesterol in large trial populations[6], interleukin-6 pathway inhibition reduced hs-CRP in a randomised phase 2 trial in people at high atherosclerotic risk[1], and in cystic fibrosis, long-term treatment with a CFTR modulator was associated with sustained reductions in inflammation[11]. A licensed provider evaluates whether any prescription treatment is appropriate for a given person.
For long-term health, lower is generally the favourable direction. Two cautions keep it honest. A low CRP does not exclude cardiovascular disease, because atherosclerosis driven mainly by ApoB-containing lipoproteins can progress with a quiet inflammatory signal[7]. And because the liver manufactures CRP, a low value in someone who is clearly unwell is worth discussing with a clinician rather than treated as reassurance.
Short answer, a lot can, which is why one result is a data point and three are a trend.
Testing conditions. Recent infection, a vaccination, dental work, surgery, an injury or an unusually long or intense training session in the preceding days can all lift the value temporarily. Fasting is not generally required for CRP, but assay type matters, since a standard assay cannot resolve the low end that a high-sensitivity assay reports[5]. Lab-to-lab differences and normal day-to-day biological variation both argue for repeat testing under similar conditions rather than reacting to a single number.
Medications and medical treatments. Lipid-lowering therapy, immune-modulating and biologic treatments[10], drugs targeting interleukin signalling[2] and disease-specific therapies such as CFTR modulators[11] have all been associated with lower inflammatory markers in research settings. Oestrogen-containing oral medication can move the number in the other direction. No medication should be started, stopped or adjusted to change a figure on a lab report, and a licensed provider decides whether any prescription option fits the person in front of them.
Habits and body composition. Regular aerobic activity, improved body composition and better sleep are associated with lower readings over time, though individual responses vary and no diet or supplement reliably normalises an elevated result. This article is educational and is not medical advice.
FitScript measures CRP as part of routine membership bloodwork, within a model of 150+ biomarkers tested per year, so the marker is read as a trend across repeat draws rather than a one-off snapshot.
The value is most useful in company. Read next to lipids, ApoB, metabolic markers and clotting-related measures, an inflammatory signal either lines up with other findings or stands out as something that needs explaining. Atlas, FitScript's AI health advisor, interprets the result in the context of your other markers, your history and your previous draws, and that interpretation becomes part of your FitScript, the personalised output written from your own biology.
Timing is deliberate. Testing during an acute illness or straight after an unusually hard training block gives a number that reflects that event, so a repeat draw once you are back to baseline is more informative. Where a pattern suggests treatment might be relevant, a licensed provider reviews the member and decides whether any prescription option is appropriate. Discuss your results and any treatment with a clinician or licensed provider before acting on them.
Inflammation is one input into cardiometabolic risk, so CRP is most informative read beside markers that cover the other inputs.
Interleukin-6 sits directly upstream, since it is the cytokine signal that drives hepatic CRP production, and suppressing that pathway lowers CRP in trials[1]. ESR is an older, slower inflammatory measure that reflects changes over days rather than hours, which makes it a useful complement rather than a duplicate. Fibrinogen activity bridges inflammation and clotting, both of which feature in the thrombotic side of atherosclerosis[3]. Apolipoprotein B counts the atherogenic particles themselves, and the inflammation and particle pathways contributed independently to long-term outcomes in 30-year follow-up data[7]. Fasting insulin captures the metabolic pressure that often accompanies visceral adiposity, and glycaemic status can be assessed with several markers, including alternatives such as glycated albumin that have been studied where standard measures are less reliable[12]. Homocysteine adds a separate vascular-risk angle tied to B-vitamin metabolism. Ferritin is worth reading next to CRP as well, because it also rises with inflammation and can make low iron stores look normal, which our guide on how to increase ferritin levels covers in more depth.
C-reactive protein is a fast-moving, non-specific signal that inflammation is active. Typical lab ranges put most adults under 3 mg/L, optimization targets sit lower, and a single high value means far less than a sustained one. It predicts cardiovascular risk in ways cholesterol alone does not, it responds to infection and exercise as readily as to chronic disease, and it is only interpretable alongside the rest of your bloodwork and your history. If a result is outside the standard range, repeat it when you are well and review the pattern with a clinician.
To go deeper on the markers that pair with it, see the biomarker pages for Homocysteine, Fibrinogen Activity, Apolipoprotein B, Fasting Insulin, ESR and Interleukin-6, or see how these markers fit together on the Heart Health panel.
Calculators that use C-Reactive Protein:
It measures the concentration of an acute-phase protein made by the liver in response to immune signalling, reported in mg/L. The value reflects how much inflammation is active in the body at the time of the draw, not where that inflammation is located or what is causing it.
Most labs use 0 to 3 mg/L as a typical adult reference range, so results above that are described as outside the standard range. Values above roughly 10 mg/L usually reflect an acute process such as infection or injury and are generally rechecked once the person has recovered, since an acute spike says little about baseline risk.
They measure the same protein with different assay sensitivity. A standard CRP assay is used to detect and follow acute inflammation, while a high-sensitivity assay resolves small differences at the low end of the range, which is what matters when the question is long-term cardiovascular and metabolic risk.
Yes. An unusually long or intense session in the days before a blood draw can temporarily raise the value as part of normal muscle repair. Regular aerobic training, by contrast, is associated with lower readings over time. Testing after a few easy days gives a result that better reflects your baseline.
No. Inflammation is one risk input among several, and atherosclerosis driven mainly by ApoB-containing lipoproteins can progress with a low inflammatory signal. A low CRP should be read alongside lipids and metabolic markers, not instead of them.
Fasting is not generally required for this marker alone, though it is often drawn with lipid and glucose tests that may have their own instructions. Follow the guidance given with your lab requisition, and avoid testing during an acute illness if the goal is a baseline reading.
Improved body composition, regular aerobic activity and better sleep can go with lower readings over time. Individual responses vary, and no supplement or diet reliably normalises an elevated value. Any persistent elevation is worth reviewing with a clinician rather than self-treating.
Because the marker moves quickly, it is most useful tracked across repeat draws under similar conditions rather than read once. A practical approach is to recheck after an elevated result once you are free of acute illness, then follow it on the same schedule as the rest of your bloodwork, with the trend reviewed by a clinician.